Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

CAPS Rating: 2 out of 5

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.

Recs

0
Player Avatar granny092 (< 20) Submitted: 6/25/2012 7:19:27 PM : Outperform Start Price: $9.63 ARNA Score: -39.32

Safe drug after many years of testing;FDA had no problems with it at the ad-com meeting on (5/10). People on panel had problems about cancer and valve problems because of consistant bashing by adversaries the prior year. FDA was satisfied with the CRL from Arena.

Member Avatar cris4344 (< 20) Submitted: 6/25/2012 11:24:24 PM
Recs: 0

I agree!!!!!!!!It's a great drug which will help everyone with the problem of obesity , it will also help people with other addictions as well.

Featured Broker Partners


Advertisement